Dear Editor,
Inflammatory bowel disease (IBD), a complex syndrome characterized by chronic inflammation of the gastrointestinal tract, is considered a global health problem, especially prevalent in western developed countries and with accelerating incidence in the develo** world over the last decade. All data and materials are presented in the main manuscript or supplementary materials and are available on request. RNA and 16 s rDNA sequencing data were deposited into Sequence Read Archive (SRA) with the Bio-project ID of PRJNA833575 and PRJNA855381. **ao, P. et al. Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10. J. Exp. Med. 216, 337–349 (2019). Rath, E., Moschetta, A. & Haller, D. Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis. Nat. Rev. Gastroenterol. Hepatol. 15, 497–516 (2018). Rath, E. et al. Induction of dsRNA-activated protein kinase links mitochondrial unfolded protein response to the pathogenesis of intestinal inflammation. Gut 61, 1269–1278 (2012). Mancini, N. L. et al. Perturbed Mitochondrial Dynamics Is a Novel Feature of Colitis That Can Be Targeted to Lessen Disease. Cell Mol. Gastroenterol. Hepatol. 10, 287–307 (2020). Hou, K. et al. Microbiota in health and diseases. Signal Transduct. Target Ther. 7, 135 (2022). This work was supported by the National Key Research and Development Program of China (2020YFA0113003, 2018YFC1004803), the Natural Science Foundation of China (31630083, 82071063), CAMS Innovation Fund for Medical Sciences (2022-I2M-1-012), and the Fundamental Research Funds for the Central Universities. We are grateful to Dr. Min-**n Guan (Zhejiang University) for valuable suggestions and support, Dr. Yanchun Ji (The Children’s Hospital, Zhejiang University School of Medicine), and Dr. Feilong Meng (The Children’s Hospital, Zhejiang University School of Medicine), and Dr. Juan Du (The First Affiliated Hospital, Zhejiang University School of Medicine) for technical support. Y.C, R.C. Zhao, and JZ.S conceptualized the study. Q.Z, H.C, J.Z, P.L, LD.Y, RL.P, and D.L performed the experiments and analyzed the data. Q.Z, JZ.S, R.C. Zhao, and Y.C interpreted the data and wrote the manuscript. All authors have read and approved the article. The authors declare no competing interests. The study protocol was approved by the Institutional Review Board of Zhejiang University and all animal procedures were performed according to protocols approved by the Institutional Animal Care and Use Committee at Zhejiang University (application ID: 18021). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Zhao, Q., Chang, H., Zheng, J. et al. A novel Trmt5-deficient zebrafish model with spontaneous inflammatory bowel disease-like phenotype.
Sig Transduct Target Ther 8, 86 (2023). https://doi.org/10.1038/s41392-023-01318-6 Received: Revised: Accepted: Published: DOI: https://doi.org/10.1038/s41392-023-01318-6 Inflammopharmacology (2024)Data availability
References
Acknowledgements
Author information
Authors and Affiliations
Contributions
Corresponding authors
Ethics declarations
Competing interests
Ethics declarations
Supplementary information
Rights and permissions
About this article
Cite this article
This article is cited by
The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease